Antisense RNA to inducible nitric oxide synthase reduces cytokine-mediated brain endothelial cell death

Annals of the New York Academy of Sciences

Volumn 1042, Issue , 2005, Pages 439-447

  Yang, Ding I ^a   Chen, Shawei ^b   Ezekiel, Uthayashanker R ^b   Xu, Jan ^b   Wu, Yingji ^b   Hsu, Chung Y ^b,c  

^a TZU CHI UNIVERSITY   (Taiwan)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Endothelial cells; Interferon ; Tumor necrosis factor ; Von Willebrand factor

Indexed keywords

COMPLEMENTARY RNA; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ANIMAL CELL; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; NONHUMAN;

EID: 22044455769     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1338.037     Document Type: Conference Paper

References (13)

1. PALMER, R.M. et al. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526.
2. XIE, Q.W. et al. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228.
3. HSU, C.Y. et al. 1997. Enhancement of apoptosis in cerebral endothelial cells by selected inflammatory signals. Ann. N.Y. Acad. Sci. 843: 148-153.
4. RAUHALA, P. et al. 1998. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J. 12: 165-173.
5. TOMIMOTO, H. et al. 1994. Distribution of nitric oxide synthase in the human cerebral blood vessels and brain tissues. J. Cereb. Blood Flow Metab. 14: 930-938.
6. HUANG, P.L. et al. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242.
7. XU, J. et al. 1997. Regulation of cytokine-induced iNOS expression by a hairpin oligonucleotide in murine cerebral endothelial cells. Biochem. Biophys. Res. Commun. 235: 394-397.
8. XU, J. et al. 1998. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-α/cycloheximide-induced cerebral endothelial cell death. J. Biol. Chem. 273: 16521-16526.
9. PARK, J.H. et al. 2002. Nitric oxide (NO) pretreatment increases cytokine-induced NO production in cultured rat hepatocytes by suppressing GTP cyclohydrolase I feedback inhibitory protein level and promoting inducible NO synthase dimerization. J. Biol. Chem. 277: 47073-47079.
10. DE NADAI, C. et al. 2000. Nitric oxide inhibits tumor necrosis factor-alpha-induced apoptosis by reducing the generation of ceramide. Proc. Natl. Acad. Sci. USA 97: 5480-5485.
11. WRIGHTON, C.J. et al. 1996. Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B. J. Exp. Med. 183: 1013-1322.
12. AIRD, W.C. et al. 1995. Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc. Natl. Acad. Sci. USA 92: 4567-4571.
13. OZAKI, K. et al. 1996. Use of von Willebrand factor promoter to transduce suicidal gene to human endothelial cells, HUVEC. Hum. Gene Ther. 7: 1483-1490.